Experience
Represented a major biotech company in patent litigation and parallel PTAB proceedings that resulted in a significant jury verdict finding willful infringement.
Represented a leading medical technology company in a patent infringement dispute over metal devices used to prevent bleeding in the GI tract in minimally invasive surgeries.
Represented a major pharmaceutical and biotechnology company in a district court litigation and copending Post-Grant Review (PGR) petition relating to a monoclonal antibody therapy.
Represented a major biopharmaceutical company in two inter partes reviews (IPRs) of patents relating to peptide therapeutics.
Advised a pharmaceutical investment company on its acquisition of a partial royalty interest in a specific antiviral medication from a European anti-infective company.